Bone Marrow and Kidney Findings at Odds: A Case Report and Review of Literature of Divergent Pathology in Chronic Myeloid Leukemia

Abstract

Chronic myeloid leukemia (CML) is a hematologic malignancy driven by the BCR-ABL1 fusion gene, which results in the abnormal proliferation of myeloid cells. The disease typically has two phases: chronic (CP) and blast crisis (BC). Extramedullary blast crisis (EBC) in CML refers to the presence of blast cells in extramedullary sites, irrespective of the blast proliferation occurring in the bone marrow. Renal infiltration of blasts as the initial presentation of CML is exceedingly rare. We present a case of a 51-year-old man with renal failure. Renal biopsy showed myeloperoxidase staining blasts, with bone marrow in CP. Based on the presence of EBC, the patient was diagnosed with CML in BC, despite the CP in the bone marrow, a rare occurrence that challenges conventional diagnostic pathways.

Keywords

acute kidney injury - blast phase - chronic myeloid leukemia - chronic phase - extramedullary blast crisis - tyrosine kinase inhibitors

Patient's Consent

Informed consent has been taken by the patient.

Publikationsverlauf

Artikel online veröffentlicht:
20. August 2025

• References

• 1 Jabbour E, Kantarjian H. Chronic myeloid leukemia: a review. JAMA 2025; 333 (18) 1618-1629
• 2 Apfelbeck U, Hoefler G, Neumeister P, Fonatsch C, Linkesch W, Sill H. Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation. Bone Marrow Transplant 2000; 26 (10) 1111-1112
• 3 Inverardi D, Lazzarino M, Morra E. et al. Extramedullary disease in Ph'-positive chronic myelogenous leukemia: frequency, clinical features and prognostic significance. Haematologica 1990; 75 (02) 146-148
• 4 Sahu KK, Malhotra P, Uthamalingam P. et al. Chronic myeloid leukemia with extramedullary blast crisis: two unusual sites with review of literature. Indian J Hematol Blood Transfus 2016; 32 (Suppl. 01) 89-95
• 5 Specchia G, Palumbo G, Pastore D, Mininni D, Mestice A, Liso V. Extramedullary blast crisis in chronic myeloid leukemia. Leuk Res 1996; 20 (11-12): 905-908
• 6 Yuzawa Y, Sato W, Masuda T. et al. Acute kidney injury presenting a feature of leukemic infiltration during therapy for chronic myelogenous leukemia. Intern Med 2010; 49 (12) 1139-1142
• 7 Swerdlow SH, Campo E, Pileri SA. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127 (20) 2375-2390
• 8 Hehlmann R. How I treat CML blast crisis. Blood 2012; 120 (04) 737-747
• 9 Sun T, Susin M, Koduru P. et al. Extramedullary blast crisis in chronic myelogenous leukemia. Demonstration of T-cell lineage and Philadelphia chromosome in a paraspinal tumor. Cancer 1991; 68 (03) 605-610
• 10 Aleem A, Siddiqui N. Chronic myeloid leukemia presenting with extramedullary disease as massive ascites responding to imatinib mesylate. Leuk Lymphoma 2005; 46 (07) 1097-1099
• 11 Mishra R, Garg S, Bharti P, Malla DR, Rohatgi I, Gautam S. Unusual presentation of extramedullary blast crisis in chronic myeloid leukemia: a case report. World J Hepatol 2023; 10 (04) 42-47
• 12 Chen Z, Wang W, Rich A, Tang G, Hu S. Myeloid sarcoma as the initial presentation of chronic myelogenous leukemia, medullary chronic phase in era of tyrosine kinase inhibitors: a report of 11 cases. Am J Hematol 2015; 90 (08) E146-E148
• 13 Lee HJ, Gu MJ, Kong E, Lee JM. Chronic phase of chronic myeloid leukemia presenting with myeloid sarcoma in an adolescent. Blood Res 2020; 55 (02) 112-115
• 14 Gao X, Li J, Wang L. et al. Bilineal extramedullary blast crisis as an initial presentation of chronic myeloid leukemia: a case report and literature review. Am J Case Rep 2016; 17: 793-798
• 15 Söderlund S, Dahlén T, Sandin F. et al. Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register. Eur J Haematol 2017; 98 (01) 57-66
• 16 Hochhaus A, Baccarani M, Silver RT. et al. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia 2020; 34 (04) 966-984
• 17 Jain P, Kantarjian HM, Ghorab A. et al. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: cohort study of 477 patients. Cancer 2017; 123 (22) 4391-4402
• 18 Gratwohl A, Pfirrmann M, Zander A. et al; SAKK, German CML Study Group. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia 2016; 30 (03) 562-569
• 19 Shah NP, Bhatia R, Altman JK. et al. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2024; 22 (01) 43-69